# US 2005/0090516 A1 · Novel substituted imides

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2005/0090516 A1
- Document ID: US20050090516A1
- Status: Published application
- Kind: A1
- Application number: 10/989,945
- Filed: 2004-11-16
- Published: 2005-04-28
- Earliest claimed: 1994-12-30
- Assignees: Celgene Corporation
- Inventors: George Muller; Mary Shire; David Stirling
- Web page: https://patentgrep.com/patent/US20050090516A1

## CPC

- C07D 209/48: with oxygen atoms in positions 1 and 3, e.g. phthalimide
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P 31/12: Antivirals
- A61P 35/00: Antineoplastic agents
- A61P 37/00: Drugs for immunological or allergic disorders
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07D 209/46: with an oxygen atom in position 1
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

Novel imides are inhibitors of tumor necrosis factor alpha and can be used to combat cachexia, endotoxic shock, and retrovirus replication. A typical embodiment is (R)-2-Phthalimido-3-(3′,4′-dimethoxyphenyl)propane.

## Claims

### Claim at position 1

1-20. (canceled)

### Claim 21

A method of treating in a mammal a disease selected from the group consisting of arthritis, rheumatoid arthritis, osteoarthritis, reperfusion injury, congestive heart failure, Crohn's disease, ulcerative colitis, systemic lupus erythrematosis, hyperoxic alveolar injury, graft versus host disease, fibrotic disease, chronic obstructive respiratory disease, adult respiratory distress syndrome, sarcoidosis, psoriasis, multiple sclerosis, endotoxemia and toxic shock syndrome, malaria, leprosy, cachexia, and acquired immune deficiency syndrome comprising administering to a patient in need thereof a substantially pure R or S isomer of a compound of formula (I):
wherein,
R1 is phenyl which is substituted with one or more substituents each independently selected from the group consisting of nitro, cyano, trifluoromethyl, carbethoxy, carbomethoxy, carbopropoxy, acetyl, carbamoyl, acetoxy, carboxy, hydroxy, amino, alkyl of 1 to 10 carbon atoms, alkoxy of 1 to 10 carbon atoms, and halo;
R2 is alkyl of 1 to 10 carbon atoms, phenyl, pyridyl, heterocycle, —CH2-aryl, or —CH2-heterocycle;
R3 is
(i) ethylene,
(ii) vinylene,
(iii) vicinal alkylene of 3 to 10 carbon atoms,
(iv) vicinal alkenylene of 3 to 10 carbon atoms,
(v) cycloalkylene of 4 to 9 carbon atoms, unsubstituted or substituted with 1 to 2 substituents each selected independently from the group consisting of nitro, cyano, trifluoromethyl, carbethoxy, carbomethoxy, carbopropoxy, acetyl, carbamoyl, acetoxy, carboxyl hydroxy, amino, substituted amino, alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms, and halo,
(vi) cycloalkenylene of 4 to 9 carbon atoms unsubstituted or substituted with 1 to 2 substituents each selected independently from the group consisting of nitro, cyano, trifluoromethyl, carbethoxy, carbomethoxy, carbopropoxy, acetyl, carbamoyl, acetoxy, carboxy, hydroxy, amino, substituted amino, alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms, and halo, or
(vii) o-phenylene unsubstituted or substituted with 1 to 2 substituents each selected independently from the group consisting of nitro, cyano, trifluoromethyl, carbethoxy, carbomethoxy, carbopropoxy, acetyl, carbamoyl, acetoxy, carboxy, hydroxy, amino, substituted amino, alkyl of 1 to 4 carbon atoms, alkoxy of 1 to 4 carbon atoms, and halo; and
R4 is —CH2— or —CX in which X is O or S.

### Claim 22 (depends on 21)

A method of treating a cancerous condition in a mammal, which condition is sensitive to a compound recited in claim 21, comprising administering to the mammal, an effective amount of said compound.
